Sayar Abdulkhakov Russian FederationDr Sayar Abdulkhakov, MD, PhD, is a head of Department of Fundamental Basis of Clinical Medicine, Institute of Fundamental Medicine and Biology, Kazan Federal University (Kazan, Russia) and a practicing gastroenterologist. After he completed his PhD in 2004 at Kazan State Medical University, Kazan, Russia he took specialization in gastroenterology. Besides, he is one of the team members of the research project on evaluation of tobacco heating system performed at Kazan Federal University.
David Abrams USABorn in South Africa, Dr David Abrams is a Professor of Social and Behavioral Sciences at New York University College of Global Public Health. With degrees in Psychology and Computer Science, David is a licensed clinical psychologist specializing in nicotine use, addictions and chronic disease prevention. Along with over 300 scholarly articles, he authored The Tobacco Dependence Treatment Handbook, winner of a book of the year award. Throughout his 40+ year career, he has specialized in harm reduction, addictive behaviour, tobacco and nicotine use and improving quality of life. His present focus is aligning complex systems forces to end smoked tobacco use behaviors and replace deadly smoking with safer smokeless modes of nicotine delivery.
Jason Adamson UKJason Adamson joined BAT R&D in 2008 as a Biomedical Scientist working in Bioscience, In Vitro and Pre-Clinical roles. He developed multiple aerosol exposure systems and dosimetry techniques which have supported pre-clinical assessment of potentially reduced risk products (PRRPs) and supported validation of external laboratories in UK, US and China with their new exposure systems. Jason also spent 2 years in R&D’s Tobacco Heating Product Science Team. These achievements have resulted in 22 published manuscripts to date. Currently Jason is project managing BAT’s Population Studies, comprising post-market surveillance of PRRPs, as well as managing other consumer use behaviour studies involving vapour products and modern white oral products.
Adebisi Yusuff Adebayo Nigeria @prof_rxAdebisi Yusuff Adebayo is the associate director for research at Global Health Focus Africa. He has a background in Pharmacy from the University of Ibadan, Nigeria and also earned diploma in Addiction Medicine from the University of British Columbia, Vancouver. Adebisi is a global health enthusiast, drug policy advocate, research enthusiast and public health educator. He is a graduate of Global Health Pharmacy where his interest in drug policy, smoke-free world and research emanated. He is an astute advocate for harm reduction and drug policy. Adebisi has also served as the President of Students for Sensible Drug Policy where he actively advocate for ending war on drugs. He is also a member of many international organizations in the space of public and global health.
Karolien Adriaens BelgiumKarolien Adriaens obtained her Master’s degree in Clinical Psychology in 2014. During her Masters, she conducted one of the first RCT’s concerning electronic cigarettes. Currently, she is pursuing a Ph.D. in Psychology at the Centre for the Psychology of Learning and Experimental Psychopathology at the KU Leuven in Belgium. Her main research interests are tobacco harm reduction, electronic cigarettes, and newly developed harm reduction tools, such as heat-not-burn cigarettes. Karolien is investigating the effect of electronic cigarettes as a harm reduction tool in different groups of current smokers: first time e-cigarette users, dual users and smokers who visit a tobacco counselor to quit smoking.
Spike Babaian USASpike Babaian, MA, is a former adjunct professor from New York City, using e-cigarettes since 2008. She founded the first consumer group for vapers, in 2009. She co-authored the first peer reviewed paper in the US on vapor toxicity. In 2011, she opened VapeNY, a vape shop which has grown to 4 locations. She has day to day contact with tens of thousands of vapers. She has consulted with hundreds of politicians, researchers, media outlets and government bodies regarding e-cigarettes for more than 10 years to educate academia, scientists and the public on vapor product use and safety.
Terry Barnes Australia @TerryBarnes5Terry Barnes is an Australian policy analyst, political commentator and currently Fellow of the UK Institute of Economic Affairs. He has written and spoken extensively on excessive health regulation in Australia, especially in relation to Tobacco Harm Reduction. He also advises THR advocates working to ensure the regulatory environment accepts and not rejects disruptive innovations including vaping.
Clive Bates UK @Clive_BatesClive Bates has had a diverse career in the public, private and not-for-profit sectors. He started out with the IT company, IBM, then switched career to work in the environment movement. From 1997-2003 he was Director of Action on Smoking and Health (UK), campaigning to reduce the harms caused by tobacco. In 2003 he joined Prime Minister Blair’s Strategy Unit as a civil servant and worked in senior roles in the public sector and for the United Nations in Sudan. He is now Director of Counterfactual, a consulting and advocacy practice focussed on a pragmatic approach to sustainability and public health.
Peter Beckett UK @peterbeckettPeter Beckett is Director of Public Policy for the Europe, the Middle East and Africa Region at JUUL Labs. Before joining JUUL his consulting company helped countless vaping companies comply with vape-specific rules around the world; and before that he was Head of Public Policy for the Electronic Cigarette Industry Trade Association, where he worked on the legislative process that gave birth to the EU Tobacco Products Directive.. He is also a co-founder of the vaping.com group, which also holds the largest vaping community in the world, e-cigarette-forum.com.
Atakan Befrits SwedenAtakan Erik Befrits is a Turkish/Swedish tobacco harm reduction advocate, policy researcher and harm reduction entrepreneur. Mr Befrits works for the global recognition and adoption of tobacco harm reduction as a vital and crucial tool for better public health and argues that tobacco harm reduction is clearly stipulated as mandatory in the Framework Convention on Tobacco Control. His primary area of advocacy is to internationally provide information on food grade smokeless tobacco (aka snus or snus-analog products) being viable, affordable and 98% harm reduced alternatives to smoking
Neal Benowitz USANeal L. Benowitz, MD, is Professor of Medicine and Bioengineering & Therapeutic Sciences, and Chief of the Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco. He received his medical degree from the University of Rochester School of Medicine in 1969, following which he served as a resident in internal medicine at the Bronx Municipal Hospital Center from 1969 to 1971. He then completed a postdoctoral fellowship in clinical pharmacology at UCSF. His research interests have focused primarily on the human pharmacology and toxicology of nicotine. He has published more than 600 research papers. Dr Benowitz maintains an active clinical practice in cardiovascular medicine and medical toxicology
Aaron Biebert USA @BiebertAaron Biebert, Director & Executive Producer of "A Billion Lives", won top honors for his documentary, including the Supreme Jury Prize and Best Director at the July 2016 Melbourne Documentary Film Festival in Australia, a Remi Award at the Worldfest International Film Festival in Houston, and the Dorn Award from the Global Forum on Nicotine. Aaron’s production company, Attention Era Media, is one of the most successful video production and digital social media companies in the Midwest. Producing commercials and short films for clients such as Applebee’s, IndyCar, the NCAA, the Make-A-Wish Foundation, and inner-city education initiatives, Attention Era balances the firm’s client load between for-profit and passion projects.
Oscar Camacho UKOscar holds a BSc in Mathematics with Statistics, as well as and MSc in Biometrics and an MSc in Applied Bioinformatics and joined British American Tobacco in 2010 as a technical specialist in statistics. He is now the Data Management & Statistics Manager leading a group of data scientists who provide support in statistics, bioinformatics and mathematical modelling to R&D; guiding our scientists to ensure sound data analysis techniques, data dissemination and design of efficient experiments are applied throughout studies’ life cycle.
Pasquale Caponnetto ItalyPasquale Caponnetto is researcher and contract Professor of General and Clinical Psychology at the University of Catania (Italy). His research has focused on tobacco addiction among adolescents and adults and worked on studies of mental illnesses, asthma, diabetes and electronic cigarettes. He has accumulated years of experience in dealing with tobacco addiction in different settings and for different populations. He is currently working on electronic cigarettes, tobacco harm reduction, cognitive functioning and smoking or vaping, smoking and diabetes and consumer behavior. He is also PhD candidate at the University of Stirling (UK).
Massimo Caruso Italy @mascaru74Massimo Caruso is a PhD in Respiratory Diseases, adjunct Professor of Pathology and Immunopathology and researcher at the Center of Excellence for the Acceleration of HArm Reduction (CoEHAR), a Research Center at the University of Catania. In the early years of career his work was focused on diagnostic and prognostic biomarkers in asthma. Over the last ten years his interest switched to the assessment of the damage induced by cigarette smoke in respiratory diseases, but also in cellular models. He is currently working on the study of biological impact of electronic nicotine delivery systems (ENDS) for the tobacco harm reduction.
Suely Castro UKIn her role as a strategic advocacy and public affairs adviser, Suely Castro worked with a number of clients during international negotiations at the Framework Convention on Tobacco Control Conferences of the Parties in Geneva, South Korea and New Delhi. She also worked for the Centre for Substance Use Research, managing research exploring vapers' perceptions and experiences of using electronic cigarettes, as well as conducting surveys and running focus groups on Novel psychoactive substances (NPS). Using her experience in policy development and within regulatory frameworks, corporate events, business development and multi-project management, at Knowledge·Action·Change Suely is responsible for the planning and delivery of the Global State of Tobacco Harm Reduction roadshow events, taking the report to audiences around the world.
Samrat Chowdhery India @samratSamrat Chowdhery leads consumer advocacy in India with a focus on tobacco harm reduction for users of both combustible and dangerous smokeless tobacco products. A former journalist, Mr Chowdhery is the founder-director of Association of Vapers India, and Secretary/Treasurer of the International Network of Nicotine Consumer Organisations. He was honoured with the ‘Advocate of the Year’ award at the Global Forum for Nicotine held in Warsaw in June 2018. Mr Chowdhery is currently working on a project that evaluates the efficacy and affordability of lower-risk alternatives for bidi smokers and khaini/gutka users.
Gregory Conley USA @GregTHRGregory Conley is the president of the American Vaping Association, a nonprofit organization that champions regulatory policies toward vapor products designed to maximize the effectiveness of vaping for quitting smoking. He is one of the most prominent defenders of vaping in the United States and has appeared on CNN, Fox News, and MSNBC. Mr Conley is also an attorney and a consultant on vaping legislative and regulatory issues. He began working on vaping issues in 2010 after quitting smoking with a vapor product while in law school. He served as the pro bono legislative director for the Consumer Advocates for Smoke-Free Alternatives Association from 2011 to 2014.
Sandra Costigan UKSandra Costigan was the lead Toxicologist for Vaping Products for British American Tobacco from the time they launched their first commercial electronic cigarette. Prior to that she has worked for universities, the UK regulatory authority for medical devices (MHRA), Procter & Gamble and BAT’s traditional tobacco products. She holds degrees in Applied Toxicology, Life Sciences and Biology. As a published author on safety assessment for vaping products, she was part of the British Standards Institution (BSI) steering group that produced the first voluntary national standard for electronic cigarettes and is currently an expert in several ISO and CEN working groups developing standards for emissions of vaping products.
Sharon Cox UK @Sharon_ACoxDr Sharon Cox has over ten years’ experience working in the drug and alcohol field, including working at front-line services with some of the UK’s most deprived communities. She has a special interest in harm reduction and the use of translational methodologies in vulnerable and marginalised groups. She currently works as a Trial Manager at London South Bank University’s Centre for Addictive Behaviours Research. Her current research is focused on e-cigarette puffing patterns associated with high and low nicotine e-liquid strength, smoking and alcohol consumption within disadvantaged groups and the impact of health warning labels on reduced risk products.
Martin Cullip UK @NannyFreeStateMartin Cullip is a transport company director who uses e-cigarettes and other reduced risk nicotine products and has seen positives from his staff members quitting or reducing their smoking through vaping. He is a passionate consumer advocate for all forms of tobacco harm reduction and is an adviser to the Freedom Association’s Freedom to Vape campaign. He has a keen interest in the rapidly-evolving nicotine market and the politics surrounding it, and has taken part in consumer, industry and political events on the subject from Bournemouth to Brussels and beyond. Martin has also written and blogged for a decade on a diverse range of lifestyle and free market issues for a number of media outlets.
Geoffrey Curtin USAGeoffrey M. Curtin, Ph.D. is Senior Director, Scientific & Regulatory Affairs at RAI Services Company. Dr. Curtin’s team conducts survey research, consumer testing and population modeling in support of regulatory submissions for tobacco products. His team has worked with external researchers to develop statistical models that estimate the population health effects expected to result from changes in tobacco use behaviors.
Kim Dabelstein Petersen Denmark @dabelsteinKim Dabelstein Petersen has been the president of the Danish vaping consumer organisation DADAFO since 2014, working to establish collaborations with the various stake holders in public health in Denmark. On the international arena, he has been instrumental in getting a consumer viewpoint represented in the various standardisation efforts through both CEN and ISO. Mr Dabelstein Petersen is now a member of workgroups on both the ISO and CEN efforts to standardise vaping products. He has held the position of INNCO interim Secretary General since 2018, previously sitting on the INNCO Governing Board of Treasurer.
Annette Dalrymple UKDr Annette Dalrymple is a Scientist at British American Tobacco (BAT) based in Southampton UK Annette has a PhD from Edinburgh University and 6-years postdoctoral research before joining BAT R&D in 2007. Annette has held numerous roles at BAT and has been instrumental in developing methods with external partners to assess the toxicity of cigarette smoke and more recently the application of new laboratory methods to investigative potentially reduced risk products (PRRPs). She is an active member of the tobacco scientific community, a member of the Society of Toxicology and International Association of Dental Research.
Lynne Dawkins UK @LynneDawkinsDr Lynne Dawkins completed her PhD in 2001 and postdoctoral studies in 2006 at Goldsmiths, University of London before taking up a senior lectureship in 2006 and Readership in 2014 at the University of East London (UEL) where she co-ordinated the Drugs and Addictive Behaviours Research Group. She joined LSBU as an Associate Professor specialising in Addictions in February 2016. With over 20 years’ experience of working with smokers and, more recently, electronic cigarette users, Dr Dawkins is one of the UK’s leading authorities on e-cigarettes, having published papers on profiles of use, acute effects, puffing topographies and nicotine delivery.
Michal Dobrajc GermanyMichal Dobrajc is the chairman of the board of Germany's largest and europe's oldest electronic cigarette industry trade association "Verband des eZigarettenhandels" (VdeH), advocating for a harm reduction approach of regulation and policy regarding electronic cigarettes in Germany an on the EU level. He is also a business owner of a German retail and wholesale company since 2010 and therefore knows vaping to be the biggest chance for personal and public health both from a business and a regulatory perspective. One of the main topics of his work is raising awareness for a differentiated, proportional regulation of electronic cigarettes which take the benefits of these products into account.
James Dunworth UK @inijamesJames Dunworth is co-founder of E-Cigarette Direct, a UK vape company with a chain of high street stores in England and Wales, James has been blogging about vaping since 2009. He was involved in the first peer reviewed study into e-cigarettes, has been featured in most major UK newspapers, and made appearances on Sky News, the BBC, The Jeremy Vine Show, Hello Wales and Radio Five Live. You can find him blogging here: https://www.ecigarettedirect.co.uk/ashtray-blog
Ronald Dworkin USARonald W. Dworkin, M.D., Ph.D. is a practicing anesthesiologist. He holds a doctorate in political philosophy and teaches in the George Washington University Honors Program and is a Senior Fellow at Hudson Institute in Washington D.C., a public policy research organization. He has written four books - most recently Medical Catastrophe: Confessions of an Anesthesiologist, which examines how the politics of interpersonal relationships in health care affect patient safety; he also lays out a vision for the medical profession of the future. Dr Dworkin has published numerous essays in major American opinion journals such as The Wall Street Journal, National Affairs, and The New Atlantis, and is a regular contributor to The American Interest.
Konstantinos Farsalinos Greece @FarsalinosKKonstantinos E. Farsalinos, M.D., is a research fellow at the Onassis Cardiac Surgery Center in Athens-Greece, at the Department of Pharmacy, University of Patras-Greece and at the National School of Public Health-Greece. He has been conducting laboratory and clinical research on e-cigarettes as a principal investigator since 2011. Examples of his work include the first study on the cytotoxic effects of e-cigarette vapor on cultured cells and the immediate effects of e-cigarette use on cardiac function and coronary circulation. As of late 2018, he has published more than 70 studies and articles in international peer-reviewed scientific journals about smoking, tobacco harm reduction, and e-cigarettes. He was the handling editor and author in a book titled "Analytical assessment of e-cigarettes", published by Elsevier in 2017.
Marina Foltea Switzerland @MarinaFolteaDr Marina Foltea is founder and Managing Director at Trade Pacts, a trade and investment consultancy based in Geneva advising global companies and governmental institutions. Her main areas of expertise are international trade agreements and economic organisations, as well as public policy and affairs. She takes keen interest in the regulations and policy applicable to fast-moving consumer goods, in particular tobacco and e-cigarettes.
Arise Galil BraziliaArise Galil has a degree in Medicine from the Public University of Juiz de Fora (UFJF) and a Master's Degree and PhD in Brazilian Health from the Public University of Juiz de Fora, Juiz de For/ Minas Gerais, Brazil. She is a specialist in cardiology with training from the Institute of Cardiovascular Diseases Euryclides de Jesus Zerbini, São Paulo, Brazil. She has a Stricto Sensu specialization in nephrology (UFJF) and is part of the Effective Professor Medical School of UFJF (Internship Department). She has experience in the area of medicine, with an emphasis on cardiology, working mainly in the following subjects: arterial hypertension, diabetes mellitus, and multimorbities, especially, smoking.
Sarah Gentry UK @svgentry12Dr Sarah Gentry is an Academic Clinical Fellow in Public Health at Norwich Medical School, University of East Anglia (UEA), UK. She trained at Peninsula Medical School and has an MPhil in Public Health from the University of Cambridge and a BSc from Imperial College London. Her research interests are primarily around health improvement and health services, particularly smoking cessation for people with mental illness and the role of e-cigarettes. She has considerable experience in quantitative, qualitative and mixed-methods evidence synthesis, on subjects related to smoking cessation, school gardening interventions, research impact and eHealth interventions for people living with HIV.
Moira Gilchrist SwitzerlandDr. Moira Gilchrist was appointed Vice President Reduced Risk Products Corporate Affairs in January 2017. Prior to this she was based in our R&D function where she was Director of Scientific Engagement from 2014 to 2016. Since joining PMI in 2006, Dr. Gilchrist has worked exclusively on our Reduced-Risk Product program in roles related to Research and Development as well as Commercialization. Prior to joining PMI, Dr. Gilchrist worked in the pharmaceutical sector for more than 10 years. She was a Principal Consultant in PwC and IBM’s pharmaceutical industry consulting groups and prior to that held positions in both industry and charity sectors developing new drug formulations. Dr. Gilchrist holds a degree in Pharmacy and a PhD. in Pharmaceutical Sciences, both from the University of Strathclyde in Glasgow, Scotland.
Gene Gillman USADr Gene Gillman holds a Ph.D. in organic chemistry, with an emphasis on chemical toxicology, from Wake Forest University. He has spent his professional career investigating the constituents and chemistry of nicotine containing products. Dr Gillman is also involved in the standardization of analytical method for the analysis of tobacco, smoke and e-vapor products and he is active on the US ISO TAG to TC 126, and also serves as the Secretary of the CORESTA E-Vapour Subgroup. He is a Sr.Vice President at Enthalpy Analytical, LLC., a CRO specializing in qualitative and quantitative analyses of compounds in tobacco, tobacco smoke, and electronic cigarettes.
Marewa Glover New Zealand @MarewaGloverMarewa Glover is Director of the independent Centre of Research Excellence: Indigenous Sovereignty & Smoking based in Auckland, New Zealand but focused on tobacco use among all indigenous people globally. She is also Tobacco Section Editor for the international Harm Reduction Journal. She has led and collaborated on many studies resulting in over 100 scientific publications. Her dedication to reducing tobacco smoking harm over 25 years and advocating for a harm reduction approach to smoking was recognized with several awards. Marewa was appointed as an INNCO scientific advisor and is an associate member of the NNA UK. Marewa is a former Massey University Professor of Public Health and former Chair of End Smoking NZ.
Will Godfrey USA @godfreywillWill Godfrey is the editor-in-chief of Filter (https://filtermag.org), an online magazine covering drug use, drug policy and human rights. He's also executive director of The Influence Foundation, the nonprofit behind Filter. He was previously editor-in-chief of The Influence (2015-2017), an award-winning news site covering drug policy and related areas; Substance (2014-2015), a harm reduction-oriented magazine; and the addiction-focused site The Fix (2013). In London, he co-founded and edited Voice of the Ville, an award-winning print publication for incarcerated people (2007-2010). He lives in New York.
Maciej Goniewicz USADr Maciej L. Goniewicz is an Associate Professor of Oncology at the Department of Health Behavior, Roswell Park Comprehensive Cancer Center in Buffalo, USA. His primary research area is in nicotine pharmacology and toxicity of alternative tobacco products, with a focus on nicotine dependence and respiratory health risk. Dr Goniewicz’s current research is focused on safety and efficacy of electronic nicotine delivery devices and heated tobacco products. These studies include the laboratory evaluation of the products, pharmacological and toxicological assessment, surveys among their users, and their potential application in harm reduction and smoking cessation.
Lukasz Gruszczynski Poland @LukGruszczynskiLukasz Gruszczynski (dr. habil.) is an Associate Professor of international law at the Institute of Law Studies of the Polish Academy of Sciences and an External Research Fellow at the Institute for Legal Studies of the Hungarian Academy of Sciences. He specializes in WTO law, international dispute settlement and regulation of tobacco products. Lukasz is a Managing Co-Editor of the Polish Yearbook of International Law and a board member of the European Journal of Risk Regulation. He is also an editor of the forthcoming book “The Regulation of E-cigarettes: International, European and National Challenges” (Edward Elgar Publishing, 2019).
Peter Hajek UKPeter Hajek is Professor of Clinical Psychology and Director of the Tobacco Dependence Research Unit at the Wolfson Institute of Preventive Medicine, Queen Mary University of London. His research is concerned primarily with understanding health behaviours, and developing and evaluating both behavioural and pharmacological treatments for dependent smokers and for people with weight problems. Professor Hajek is a member of a number of expert groups, advisory bodies and editorial boards, and has authored or co-authored over 350 publications.
Thaddaeus Hannel USAThad Hannel, Ph.D. serves as a Principal Scientist in Population Science within Regulatory Sciences for Altria Client Services (ALCS) in Richmond, VA. In this role, he applies his knowledge of statistics and computational modeling to evaluate the impact of reduced risk tobacco products on population health. Prior to joining ALCS, Dr. Hannel co-founded Escent Technologies LLC with venture capital based on his research of a novel integrated sensing algorithm for the rapid identification of narcotics and prescription drugs of abuse. Dr. Hannel holds a Ph.D. in Analytical Chemistry with a focus on statistical methods and computational modeling from the University of Kentucky.
Eveline Hondius NetherlandsEveline Hondius is a marketing specialist and trainer and has been a board member of Acvoda, the Dutch vaping consumer association, since 2017. Eveline had several unsuccessful attempts to quit smoking, using Champix, NRT and cold turkey. Eveline quit with vaping two years ago, after trying her brother-in-law's e-cigarette.
Abby Hunter UKDr Abby Hunter is a Senior Research Fellow in the School of Medicine, University of Nottingham. She is a Health Psychologist with extensive experience in addiction research and public health. Her current programme of research is focused on smoking cessation in pregnancy; electronic cigarettes as a harm reduction tool; and education and training in smoking cessation among healthcare professionals. Dr Hunter also has a passion for public involvement in research and is leading a Priority Setting Partnership to identify patients and clinicians priority questions for electronic cigarette research.
Cecilia Kindstrand-Isaksson SwedenCecilia Kindstrand is Director of Public Affairs for Swedish Match, a tobacco company with tobacco harm reduction at the core of its business. She is based in Brussels and has worked extensively with the revision of the EU’s Tobacco Products Directive, a legislation banning the ‘proof of concept’ of tobacco harm reduction in 27 of the 28 Member States. The vision of Swedish Match is A World Without Cigarettes.
Patricia Kovacevic USA @patriciakovaA global legal and compliance nicotine, cannabis and CBD expert, and currently an independent consultant/principal at RegulationStrategy.com, Patricia Kovacevic’s experience comprises past General Counsel and Chief Compliance Officer roles at a leading nicotine/CBD multinational, and senior legal and regulatory positions at, among others, Philip Morris International and Lorillard. While at Lorillard, her team obtained the first ever premarket authorization for a tobacco product issued by the FDA under the Tobacco Control Act (2013). At Nicopure Labs she spearheaded the litigation against the FDA challenging the so-called “deeming rule”. Prior to joining Lorillard she was a partner at Patton Boggs. Her expertise includes global e-cigarette and tobacco regulation, cannabis regulation, compliance and all regulatory aspects of marketing/media communications,
Hiroya Kumamaru JapanHiroya Kumamaru, M.D. PhD, has been Vice Director of the AOI Universal Hospital since 2013. He graduated from the Medical School at Keio University, Japan, in 1980, before training in General Surgery and Cardiovascular Surgery at Keio University Hospital and other affiliated hospitals 1980 to 1988. He was Clinical Research Fellowship in the Dept. of Cardiovascular Surgery at St. Vincent Medical Center in LA, spent a Surgical Residency in Cardiovascular Surgery at the Centre Cardio-Thoracique de Monaco and was Staff Surgeon of Cardiovascular Surgery in affiliated hospitals until 2008. From 1996 to 2005 he was Cardiovascular Medical Director for Pfizer Japan, and from 2008 to 2013, he ran a private practice in the Tokyo Metropolitan area focusing on smoking cessation.
David Levy USADavid Levy has a PhD in Economics from UCLA (USA), and is currently a Professor of Oncology at Georgetown University. He has published over 250 articles, including in the American Economic Review, the BMJ, the AJPH, the JAMA, Lancet, Tobacco Control, and PLOS Medicine. He has been principal investigator of grants from the CDC, WHO, the National Cancer Institute, and Bloomberg/Gates Foundation. Dr. Levy is currently overseeing the design and development of the SimSmoke tobacco policy simulation model, for which he has developed models for over 40 countries covering 85% of the world population. He is now developing models of smokeless tobacco and e-cigarette use.
David MacKintosh UKDavid MacKintosh is the Head of Community Safety for the City of London, and has also been the Policy Adviser/Director to the London Drug and Alcohol Policy Forum (LDAPF) since 2001. He has been involved in a number of innovative campaigns around issues including drug driving, substance misuse in the workplace and improving awareness around drug safety in clubs and pubs. The LDAPF is funded by the City of London as part of its commitment to improving the life of all those who live and work in London. For the last eight years he has also been seconded to the Greater London Authority to provide advice around substance use issues and health inequalities.
Joseph Magero Kenya @JosephmageroJoseph Magero is an avid tobacco harm reduction advocate. He has spent a decade working in tobacco control as the former director of the Africa Tobacco-Free Initiative, but after extensive research, consultation, and direct engagement with ex-smokers, scientists and tobacco harm reduction consumer advocates, he became convinced that giving smokers the option of switching to significantly safer (and enjoyable) nicotine products could provide a vital addition in reducing smoking related diseases. He is currently the chairman of Campaign For Safer Alternatives, a regional organisation that advocates for the adoption of tobacco harm reduction policies in Africa. His commitment to a smoke-free future remains undiminished.
Kevin McGirr USAKevin McGirr, Clinical Professor at the University of California San Francisco School of Nursing; has taught in schools of medicine, social work and public health and was a Nehru-Fulbright Scholar in Pondicherry India, 2013-2014. He has extensive experience in providing and managing behavioral health services in Boston, San Francisco and New York. He holds masters degrees in public health, psychiatric nursing and an all but dissertation doctorate in public health. He has an interest in the utilization of harm reduction in substance use services and in particular utilizing Harm Reduction Tobacco interventions for persons with serious mental illness.
Andy Morrison UK @GMFCfantasyEx Royal Air Force, and now a self-employed IT specialist living in Scotland, Andy Morrison now works mainly in the whisky industry. Andy was a pack-a-day smoker for 40 years and of the mindset that nobody would ever get him to stop smoking. He accidentally switched to vaping in December 2011 and never looked back. On hearing about possible impending bans and listening to some of the junk science which seemed to be fueling the proposed regulations, Andy decided that it was time for him to try to do something about it. Andy assisted with various studies in central Scotland surrounding vaping. He is currently involved in four separate UK projects, all dedicated to e-cigarettes and harm reduction. He is also an associate of the NNA UK.
Ángeles Muntadas-Prim @AahoogaÁngeles Muntadas-Prim (bachelor’s degree in Fine Arts from Barcelona University) chairs the Spanish Association Supporting Vapers (ANESVAP). Formed in 2014, ANESVAP is the only association in Spain defending vapers’ rights. ANESVAP is also a founding member of INNCO, and she serves on INNCO’s Governing Board. She’s co-founder/organizer of the THR Summit Spain (2018), which gathered tobacco harm reduction experts from around the world. She has been instrumental in promoting the Tobacco Harm Reduction Platform in Spain (2019) for doctors and scientists and in the creation of AHL Provape, a network of organisations in Latin America focused on vaping and THR. She meets with various politicians, medical associations, and media and also attends various events and political rallies in order to ensure that consumers are represented.
Chimwemwe Ngoma Malawi @ThamoMthuziChimwemwe Ngoma is a social scientist and a tobacco harm reduction advocate, he is implementing an information dissemination project on tobacco harm reduction and nicotine science in Malawi. He leads a group of 24 tobacco harm reduction volunteer ambassadors in Malawi and Zimbabwe. Chimwemwe has worked as a Project and Resource Mobilisation Officer at Drug Fight Malawi. Whilst in college he undertook a research study on “the prevalence of drug and substance abuse in Malawian colleges”.
Caitlin Notley UK @caitlinnueaDr Notley is a Senior Lecturer in Mental Health at the Norwich Medical School, University of East Anglia, and lead of the Addictions Research Group. She is a social scientist with extensive experience in all aspects of addiction research. Her current programme of research is focused on tobacco smoking relapse prevention, particularly working with vulnerable groups. Dr Notley’s research interests in alternative nicotine delivery devices primarily explores social and culturally pertinent aspects of vaping. Her work emphasises the public health potential of vaping for smoking relapse prevention, taking a ‘real world’ approach to highlight the importance of user focused perspectives on switching from traditional smoking to vaping.
Tomás O'Gorman MexicoTomás is a Mexican lawyer and teaches Corporation Law and Successions Law at Universidad Panamericana in Mexico City. An ex smoker and vaper since 2016, he is co-founder of "Pro-Vapeo Mexico", a Mexican consumer association (registered in 2017), that advocates for tobacco harm reduction and non-combustible alternatives.
Uche Olatunji NigeriaUche Olatunji is a BSc holder in Business Administration. As a Community Education Specialist, Uche focused on teacher training, youth empowerment and promoting HIV/AIDS prevention, this amongst other reasons led him to joining the advocacy for tobacco harm reduction. Uche is an active board member of Campaign for Safer Alternatives - CASA, Africa. He is the head of the West Africa region, where he advocates for tobacco harm reduction in the region and partly in Kenya. His future plans includes pursuing a career in counseling and gaining more knowledge in the healthcare field in order to push further the agenda of harm reduction. He desires to apply his skills to increase awareness in tobacco harm reduction.
Fiona Patten Australia @FionaPattenMLCFiona Patten is a Member for Northern Metropolitan Region in the Victorian Parliament’s Legislative Council. Leader of the Reason Party, Fiona was first elected in 2014 and re-elected in 2018. Since being elected in 2014, Fiona has garnered respect from all sides of the political divide and has worked tirelessly to deliver legislative reforms that many thought impossible. Fiona is now working towards improving Victoria even further, and is pushing to legalise and regulate cannabis for adult use, continuing to implement electoral reform, religious accountability and greater separation of church and state, legalise sex work, and spent convictions legislation.
Pooja Patwardhan UKDr Pooja Patwardhan is a practising General Practitioner (GP) in Hampshire, UK. Over the last 2 decades of her medical practice in India and UK, she has become a keen advocate of preventive medicine and is passionate about her current work in smoking cessation. She believes that a more robust, systematic and holistic approach to smoking cessation is needed and that surely includes educating and empowering healthcare practitioners globally. At the Centre for Health Research and Education (CHRE-UK), a healthcare start-up, Dr Pooja is a co-founder and Medical Director. She leads CHRE’s work on diagnosing bottlenecks and designing interventions for implementing successful smoking cessation programmes
Robert Philibert USADr. Rob Philibert is the chief executive officer and founder of Behavioral Diagnostics. After finishing his psychiatry residency in 1993, Rob completed a Pharmacology Research Associate Training Program fellowship and spent nearly six focused years on benchtop research at the National Institutes of Health in Bethesda, MD. Subsequently, he returned to the University of Iowa where he is now a professor of psychiatry with adjunct appointments in genetics, neuroscience, and biomedical engineering. He was the first to describe the gene specific effects of smoking and drinking on DNA methylation that have led to the creation of easy to perform precise assessments of substance consumption using DNA from blood or saliva.
Riccardo Polosa Italy @RiccardoPolosaRiccardo Polosa is the director of the Center of Excellence for the acceleration of HArm Reduction (CoEHAR - University of Catania, Italy). Dr Polosa is Full Professor of Internal Medicine for the same University and Director of the Center for Smoking Prevention and Treatment at the University Hospital "Policlinico-V. Emanuele” of Catania. Dr. Polosa and the CoEHAR team of researchers conduct several high-profile clinical and behavioral research in the field of smoking-related diseases. According to a bibliometric analysis, Professor Polosa is considered the most productive scientist in the world in the field of electronic cigarette research.
Sarah Pratt USASarah Pratt, Ph.D. is a clinical psychologist and an Assistant Professor of Psychiatry at the Geisel School of Medicine at Dartmouth, where she has been a full-time researcher since 2001. Her clinical and research interests and expertise primarily involve the development of interventions for people with serious mental illness (SMI) aimed at enhancing health and functioning. For the past 10 years, she has conducted numerous trials aimed at addressing tobacco addiction in SMI, including a large study of the use of incentives to encourage smoking cessation, and an evaluation of e-cigarettes for harm reduction in chronic smokers with SMI.
Mihaela Raescu Romania @DRaescuProf. Dr Mihaela Raescu is a Ph.D. in Medical Sciences – Dentistry (2002) who teaches Oral and Dental Prevention at the Titu Maiorescu University School of Dentistry in Bucharest, Romania since 2003 and is a tenured University Professor since 2015, in addition to being an active practitioner and primarius doctor. She is the Erasmus coordinator and the President of Ethical Committee. Prof. Dr Raescu graduated from the University of Craiova, School of Dentistry in 1995 and received post-graduate scholarships at the University of Birmingham (UK) and the University Claude Bernard Lyon II (France). Dr Raescu has authored and co-authored numerous studies and publications and has been a guest speaker at various professional conferences.
Helen Redmond USA @aftariakHelen Redmond is an expert in substance use with over a decade of experience working with drug users and people with mental health problems. Her current focus is on helping smokers from vulnerable groups switch to e-cigarettes. At New York Harm Reduction Educators, Helen facilitates tobacco harm reduction/vaping groups. She is a senior editor at Filter and writes about vaping and creates short Op-Docs. Helen is adjunct faculty at the Silver School of Social Work at New York University.
Deborah Robson UKDeborah Robson is a mental health nurse and researcher. Her current role involves the development, implementation and evaluation of tobacco dependence treatment initiatives for people with a mental health condition and/ or substance use disorder who smoke. She has developed online education courses and advanced skills training for treating tobacco dependence in mental health settings. Debbie is also involved in policy work e.g. she is a co-author of Public Health England commissioned reports about e-cigarettes and vaping.
Brad Rodu USA @BradRoduDr Brad Rodu is a professor of medicine and holds an endowed chair in tobacco harm reduction research at the University of Louisville, Kentucky USA. Since 1994 Rodu has authored 70 medical publications about tobacco, and he blogs at Rodu Tobacco Truth (http://rodutobaccotruth.blogspot.com/).
Christopher Russell UK @NicotineSurveysChristopher Russell is a psychologist and Deputy Director of the Centre for Substance Use Research (CSUR), Glasgow, United Kingdom. Dr Russell leads the Centre’s research programme assessing prevalence, patterns and perceptions of use of specific e-cigarette brands among adults, young adults and adolescents, and the impact of using these products on the population’s use of smoked tobacco products. These studies seek to identify e-cigarette use patterns and risk-benefit perceptions that increase the likelihood that adults and youth will start, stop or continue to smoke conventional cigarettes.
Rebecca Ruwhiu-Collins New Zealand @Rebecca_RuwhiuRebecca Ruwhiu-Collins has been working in tobacco control for over 18 years, she is currently the tobacco harm reduction lead for New Zealand’s only Indigenous Māori Public Health unit owned by iwi (tribes) and urban Māori collective, Hapai Te Hauora. Her experience ranges from delivering stop smoking treatment services, workforce and programme development to improving and innovating in service delivery and engaging with Maori and Pacific communities. Her current focus is supporting service delivery through community mobilisation to provide people with self-determination to lead their own changes for wellbeing and health. In 2015, Rebecca increased her expertise in vaping as a cessation method and developed a unique programme, Vape2Save. The programme incorporates evidenced-based treatment modalities, financial capability, community mobilisation and the use of e-cigarettes.
Asa Saligupta ThailandAsa Saligupta is director and founding member of ENDs Cigarette Smoke Thailand, a consumer group that was founded a few years ago when vaping became illegal, and it aims to legalize THR as an alternative for those who want to quit smoking. Asa received Bachelor from Assumption University, Thailand and Master from Avila University, USA. He is a lecturer at Rajabhat University & Chulalongkorn University, and presently, works as Intertrade Manager at Probiotic and Herbal manufacturing company.
Sairah Salim-Sartoni UK @SairahssQualifying in 2002 as a Health Psychologist Sairah Salim-Sartoni started her career in smoking cessation in 2003 working for both Wiltshire and Bristol Support to Stop Smoking Services. She ran group sessions, drop-in clinics and 1:1 clinics within primary care and community hospitals. It was not uncommon for her to see 60 smokers a week for some of those years. The results of her community clinic, (80% quit rate) lead to her and her colleague receiving a regional public health award. She is level 3 trained at the Maudsley Clinic and also NCSCT (National Centre of Smoking Cessation Training) trained as well, and has attended many updates. Since 2015 Sairah has run her own vaping clinic at a local workplace and as of January 2019 Sairah now works for JUUL Labs UK and as their Head of Switching.
Florian Scheibein IrelandFlorian Scheibein is a PhD Candidate studying "Novel Psychoactive Substance (NPS) Injecting in Ireland: Practices, Health Implications and Service Utilisation". He currently helps teach a Substance Misuse module as part of the third year Psychiatric Nursing curriculum in Waterford Institute of Technology. He is an active International Working Group (IWG) of Youth RISE with whom he is currently working on 'law enforcement and youth' and general best practice guidelines. He recently helped develop a homeless support health needs guidebook/online health needs support library and delivered harm reduction workshops whilst working as a Community Integration Officer for Depaul Ireland.
Norbert Schmidt GermanyNorbert “Zillatron” Schmidt, Dipl.-Inform. (~MS in computer science) is currently a member of the board of the German vaping consumers organization IG-ED. He is interested in science in general. His curiosity about vaping was raised in 2012 by increasingly unscientific, absurd claims about it from so-called “experts” swamping the media. Discovering the overwhelming lack of real science in Tobacco Control related organizations and publications was a shock. He now advocates to restore fundamental scientific values. The annual visits to the GFN are major highlights of the year.
Saul Shiffman USASaul Shiffman, Ph.D. is Research Professor of Psychology, Psychiatry, Pharmaceutical Sciences, and Clinical Translational Science at the University of Pittsburgh, and a Senior Scientific Advisor at Pinney Associates, which consults to Reynolds American and BAT on tobacco harm reduction (but not on combusted tobacco). Dr Shiffman has conducted research on nicotine and tobacco for 45 years, publishing over 400 scientific papers on topics including nicotine dependence and tobacco harm reduction. He has been honored for his work by several organizations, including the Society for Research on Nicotine and Tobacco, the Society for Behavioral Medicine, and the American Psychological Association.
Gerry Stimson UK @GerryStimsonProfessor Gerry Stimson is a public health social scientist, with over 40 years’ experience of research and advocacy. He was one of the founders of drugs harm reduction in the 1980s and helped develop and evaluate harm reduction in the UK as a response to HIV/AIDS. He has advised the UK Government, WHO, UNAIDS, UNODC, World Bank and numerous governments on issues relating to drugs, HIV infection and AIDS, and alcohol. He is an advocate for tobacco harm reduction as a key public health strategy for reducing smoking related harms. He has published over 220 scientific publications and several books. He is Honorary Professor at the London School of Hygiene and Tropical Medicine, Emeritus Professor at Imperial College London.
Roberto Sussman Mexico @RobertoSussmanDr Roberto A Sussman is a full time senior researcher and lecturer in physics at the National University of Mexico. He specializes in Theoretical Cosmology but has undertaken research and frequent peer reviewing for journals in other areas of Astrophysics. He is also the founder and Director of Pro-Vapeo Mexico, an association representing Mexican consumers of noncombustible nicotine products and is a member of INNCO. He is actively advocating for an appropriate regulation of Tobacco Harm Reduction products in Mexico. He directs and supervises the effort to spread scientific information on these products, as well as advising consumers on how to counter the misinformation and prejudice about them that is rampant throughout Latin America.
Nancy Sutthoff New Zealand @NY2NZNancy E. Sutthoff is passionate about consumers having their voices heard in the narrative of THR and public health policy. She is one of the founders of and co-directors of AVCA NZ - the first consumer only advocacy organisation for users of electronic cigarettes, and other SNP, in New Zealand. Nancy has also been involved with INNCO from its inception and is currently the Asia Pacific Regional coordinator,and has served as the past president of the Governing Board. Nancy is also the principle of Paraclete Associates Limited, to provide assistance on THR policy and regulation, THR programme development and advocacy mentoring globally. Lastly, she is the Executive Coordinator for the Coalition of Asia Pacific Harm Reduction Advocates (CAPHRA).
David Sweanor CanadaDavid Sweanor is an adjunct professor, Faculty of Law, and chair of the advisory board of the Centre for Health Law, Policy & Ethics at the University of Ottawa and has been actively involved in tobacco and health policy issues since the beginning of the 1980s. He has worked globally, and with numerous groups, including the International Union Against Cancer, World Health Organization, World Bank and the Pan American Health Organization and played a key role in achieving many global precedents in tobacco policy. He currently focuses much of his tobacco and nicotine related efforts on risk reduction strategies.
Andrew Thompson Australia @vaper_theAndrew Thompson started smoking on a daily basis at the age of 18 and continued smoking for 29 years. The cost of smoking in Australia became prohibitive, so he sought alternatives & discovered vaping. Soon thereafter he started advocating for vaping on behalf of the smokers most harmed by the large tobacco excise, those of low SES or in groups where high smoking rates were prevalent, such as those experiencing mental health issues. His advocacy work is aimed at getting nicotine legalised for retail sale, as he feels that the 'medical model' preferred by tobacco control in his home country will not meet the needs of those groups any better than the current system of (illegally) importing nicotine from outside the country.
Aleksei Trofimov Russian FederationProf. Aleksei Trofimov received M.Sc. (1988) and Ph.D. (1991) degrees in physics and mathematics from the Moscow Institute of Physics and Technology (State University) and D.Sc. ("Habilitation") degree in chemistry (2005) from the Russian Academy of Sciences. During his academic career, he held positions at the Institutes of Chemical/Biochemical Physics, Russian Academy of Sciences (Moscow, Russia), as Senior Scientist and Leading Scientist, and at the University of Würzburg (Germany), as the postdoctoral fellow and the Senior Research Associate with Prof. Waldemar Adam. Currently, he holds the position of Deputy Director of the Emanuel Institute of Biochemical Physics, Russian Academy of Sciences.
Allan Tyler UK @aptTylerDr Allan Tyler is a Research Fellow at the Centre for Addictive Behaviours Research (CABR) in the Division of Psychology at London South Bank University. Allan uses a range of qualitative methodologies and methods to address research questions relevant to social policy, gender-culture-politics and media. A self-described ‘methods geek’, his research provides detailed, personal accounts of lived experience, identity, representation, and behaviour to co-produce non-pathologising narratives with people in populations outside of clinical or traditional research settings. His research has been focused primarily on populations who have been identified as ‘hard to reach’ – sex workers, LGBTQ people accessing health services, people affected by street drinking who are not engaging in services, and most recently people experiencing homelessness and addiction. Allan’s current research is part of a National Institute of Health Research (NIHR) funded feasibility study led by Professor Lynne Dawkins, investigating e-cigarette starter kits and smoking cessation for people accessing services for homeless adults in the United Kingdom.
Clarisse Virgino PhilippinesClarisse Virgino is a law student, aiming to specialize in international public policy and advocacy. A former local newspaper contributor, she started to smoke at a young age but has now been vaping for almost a decade and found it to be the best way to end cigarette smoking. She is engaged in educating smokers on alternative products as well as the benefits in switching to these alternatives. She is also pushing for the fair regulation of Electronic Nicotine Delivery System (ENDS) or E-Cigarettes in the Philippines. She is a member of the Coalition of Asia-Pacific Tobacco Harm Reduction Advocates (CAPHRA).
Emma Ward UKDr Emma Ward is a Senior Research Associate in Norwich Medical School, and is an associate tutor teaching on the SSF MRes programme. Dr Ward is an experienced mixed methods researcher with a background in social work research and researching young people and vulnerable groups. In 2016 she become a member of the UEA Addiction Research group working on smoking relapse prevention studies. Between 2006 and 2017, Emma was contracted on various research projects within the Centre for Research on Children and Families at UEA. Emma graduated in 2009 with a PhD from UEA and she was previously an undergraduate student on the UEA BSc Psychosocial Sciences programme.
Alex Wodak AustraliaDr Alex Wodak AM is a retired physician who is now President of the Australian Drug Law Reform Foundation. he works full time on drug law reform as a volunteer. Together with colleagues, he started the first needle syringe programme (1986) and the first medically supervised injecting centre (1999) in Australia when both were pre-legal. Dr Wodak was President of the International Harm Reduction Association (1996-2004). He has been interested in tobacco harm reduction since 1992 but only active in THR in recent years. Dr Wodak helped to start the National Drug and Alcohol Research Centre (1987).
Julie Woessner USAJulie Woessner serves as President on INNCO’s Governing Board, thus representing the interests of thousands of nicotine consumers from all over the world. She is also the National Policy Director on the Board of Directors of CASAA (the Consumer Advocates for Smoke-free Alternatives Association). CASAA, a nonprofit U.S.-based public health and education nonprofit, advocates for people who consume, or might in the future consume, low-risk alternatives to cigarettes. CASAA engages in policy advocacy in the U.S. involving legislative and regulatory matters to protect access to low-risk products and mobilizes its 250,000+ members to do the same. Woessner holds a JD from Duke School of Law and was previously a practicing attorney.
Grace Wong New ZealandGrace Wong is a Senior Lecturer in Nursing at Auckland University of Technology in New Zealand. She leads Smokefree Nurses Aotearoa/New Zealand. Grace teaches primary health care and advocates for incorporating smoking cessation in nursing education and practice. Her research focuses on Asian New Zealanders, nurses and smoking cessation.
Zhenyi Zhou FranceZhenyi Zhou known also as Zed is a French tobacconist specialized in switching his customers to tobacco harm reduction products. His tobacco shop has one the biggest drop in sales’ volume year on year in France cigarettes wise. His position provides him a unique vantage point : he gets to meet and talk to smokers everyday to gauge and increase their motivation towards smoking cessation. He is convinced people will embrace vaping on a larger scale if they are informed on what vaping really is : a consumer driven alternative to smoking that is at least 95 % less harmful than smoking.